Published in Biotech Business Week, January 29th, 2007
Implementation of the scheme remains conditional upon Innovata shareholder approval at the Innovata Extraordinary General Meeting and the Innovata Court Meeting, and satisfaction of the conditions set out in the admission document posted to Innovata shareholders.
Provided that the court sanctions the arrangement and confirms the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.